Clinical Trials
3 trialsNCT04875611 2025-04-24
NIVONASO-21
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Recruiting
NCT06019130 2024-05-16
NPC-Nivo
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase 2 Recruiting
NCT02339558 2019-09-13
Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed